David Owens - 31 Dec 2024 Form 5 Insider Report for Nexalin Technology, Inc. (NXL)

Role
Chief Medical Officer, Director
Signature
/s/ David Owens Name: David Owens, M.D.
Issuer symbol
NXL
Transactions as of
31 Dec 2024
Net transactions value
+$2,750
Form type
5
Filing time
29 Jan 2025, 17:26:11 UTC
Previous filing
30 Oct 2024
Next filing
24 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXL Common stock Purchase $2,750 +1,000 +0.67% $2.75 149,293 20 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXL Stock Option (right to buy) Award $0 +262,500 $0.000000 262,500 07 Nov 2024 Common Stock 262,500 $0.9400 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.